{"schema_version":"secwatch.filing_event.v1","accession":"0001822462-25-000007","form_type":"8-K","ticker":"FHTX","cik":"0001822462","company_name":"Foghorn Therapeutics Inc.","filed_at":"2025-09-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.143578+00:00","generated_at":"2026-05-17T08:56:45.792636+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Foghorn Therapeutics releases September 2025 investor presentation without new material disclosures","bullets":["Presentation reiterates company focus on unique biology, precision therapeutics, and broad impact.","No new financial, clinical, or strategic data provided in the filing excerpt.","Intended for use in investor meetings; no guidance or material events announced.","Stock ticker FHTX listed on Nasdaq."],"urls":{"canonical":"https://secwatch.observer/filing/0001822462-25-000007","json":"https://secwatch.observer/filing/0001822462-25-000007.json","markdown":"https://secwatch.observer/filing/0001822462-25-000007.md","text":"https://secwatch.observer/filing/0001822462-25-000007.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1822462/000182246225000007/0001822462-25-000007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1822462/000182246225000007/fhtx-20250902.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T08:56:45.792636+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}